Sareum reports progress with psoriasis drug development programme
1st Oct 2014 11:54
Drug development firm Sareum and its partner SRI International have reported progress with its drug development programme for the autoimmune disease psoriasis. Psoriasis can occur when the production of cytokines is not properly regulated and immune cells are consequently overly activated. The cyct
Read moreSareum Holdings does cancer drug deal in China
2nd Dec 2013 14:17
Cancer drug developer Sareum Holdings has signed a deal with a Chinese medical university to progress its Aurora+FLT3 cancer programme. Sareum has granted the Hebei Medical University Biomedical Engineering Center exclusive rights to carry out pre-clinical and clinical studies within Greater China
Read moreSareum raises funds for further drug development
1st Nov 2013 12:34
Sareum Holdings, a cancer drug discovery and development business, has placed 278.5m shares at 0.6p each, it announced Friday. The group raised a conditional £1.67m before expenses from the placing, which it said was oversubscribed. The proceeds of the placing will provide funds to facilitate the
Read moreSareum Holdings and SRI International develop drug for inflammatory diseases
22nd Apr 2013 08:06
Cancer drug discovery business Sareum Holdings has entered into a co-development agreement with research institute SRI International. The two have joined forces to advance Sareum's Tyrosine Kinase 2 (TYK2) small molecule drug discovery programme for readiness in human clinical trials. Research wi
Read moreSareum shares fall following interims and research update
18th Feb 2013 08:21
Shares in AIM-listed Sareum Holdings, the specialist cancer drug discovery business, fell sharply on Monday morning after the company unveiled its half yearly results alongside a research update. Cash at bank as of December 31st fell 28% to £380,000 and the company reported a loss on ordinary activ
Read moreSareum share price climbs on US patent grant announcement
7th Feb 2013 08:27
The share price of AIM-listed specialist cancer drug discovery business Sareum Holdings jumped sharply on Thursday after the company announced that a patent was due to be awarded in the US for one of its key drug discovery inventions. The patent, which is expected on February 19th, relates to compo
Read moreSareum share price plummets ahead of AGM
12th Dec 2012 10:40
The likelihood that specialist cancer drug discovery business Sareum will conclude a deal to commercialise a research programme this year has fallen, according to an announcement made ahead of its annual general meeting (AGM) on Wednesday morning. During the AGM, Dr. Paul Harper, the company's Chai
Read moreSmall caps round-up: Sareum, Lonrho, FFastFill
10th Sep 2012 14:37
Sareum, a specialist cancer drug discovery business, has entered into a four million pound Standby Equity Distribution Agreement (SEDA) with YA Global Master, an investment fund to provide a flexible source of future funding to the company to support its on-going drug research activities. It will a
Read moreSmall caps round-up: YouGov, Sareum and InterQuest...
7th Aug 2012 11:25
Environmental Recycling Technologies, which owns the rights to the Powder Impression Moulding (PIM) process which is capable of converting mixed waste plastics into commercially viable products, has confirmed that its US parent application, entitled 'Process for Forming Plastic, Apparatuses for Form
Read moreSmall caps round-up: Byotrol, sareum, KDD ...
19th Jul 2012 12:07
Byotrol, an anti-microbial hygiene company, has continued to make progress and has maintained the momentum seen in the second half of last year into the current financial year. The balance sheet continues to remain strong and is well positioned to its objective of positive cash generation at the ear
Read moreSmall caps round-up: Cyan, Aer Lingus, Mobile Tornado ...
7th Jun 2012 13:59
Cyan Holdings, the wireless solutions company, has revealed that three more Cyan partners have received requests from the Tamil Nadu Electricity Board (TNEB) Automatic Meter Reading tender to proceed with installation and commissioning of 500 unit pilots within the next 25 days. The news follows Cya
Read moreSmall caps round-up: PLUS Markets, Sareum, Planet Payment
6th Jun 2012 14:22
PLUS Markets Group, which provides listing and quoting services to around 140 companies on the stock exchange, has recommended its shareholders to vote in favour of the proposed disposal of its PLUS-SX division to ICAP for a nominal sum at its general meeting on June 18th. 'The disposal will, theref
Read moreSareum confident of at least one deal in 2012
27th Feb 2012 14:57
Penny stock Sareum, which develops drugs to combat cancer, saw its losses widen in the second half of 2011, in line with the board's expectations. The firm's losses after tax deepened from £0.26m to £0.33m, which the firm said reflects an increase in research and development. Pre-tax losses totall
Read moreCancer results boost Sareum
15th Aug 2011 11:50
Cancer drug discovery business Sareum shot ahead after it said it had selected a "preclinical development candidate" from research into Chk1, a method of controlling a cancer cells' response to DNA damage. The candidate, when orally dosed, reduces cancer growth rates compared to treatment with the
Read moreSareum soars after colon cancer study
4th Mar 2011 11:08
Shares in Sareum were soaring after the cancer drug discovery business announced positive results from a study into colon cancer. The study, which was conducted by the Institute of Cancer Research, founded that Sareum's Chk1 inhibitor, used alongside a gemcitabine, a chemotherapeutic, "demonstrate
Read more